Matinas BioPharma Holdings, Inc. (MTNB)
NYSE: MTNB · CIK 0001582554 · United States
Every official Matinas BioPharma Holdings, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MTNB filings
Matinas BioPharma Holdings, Inc. documents
- Matinas BioPharma Holdings, Inc. 10-K 2026MTNB 10-K 2026: annual report for fiscal 2026
- Matinas BioPharma Holdings, Inc. 10-K 2025MTNB 10-K 2025: annual report for fiscal 2025
- Matinas BioPharma Holdings, Inc. 10-K 2024MTNB 10-K 2024: annual report for fiscal 2024
- Matinas BioPharma Holdings, Inc. 10-K 2023MTNB 10-K 2023: annual report for fiscal 2023
- Matinas BioPharma Holdings, Inc. 10-K 2022MTNB 10-K 2022: annual report for fiscal 2022
- Matinas BioPharma Holdings, Inc. 10-Q 2026MTNB 10-Q 2026: quarterly report for fiscal 2026
- Matinas BioPharma Holdings, Inc. 10-Q 2025MTNB 10-Q 2025: quarterly report for fiscal 2025
- Matinas BioPharma Holdings, Inc. 10-Q 2024MTNB 10-Q 2024: quarterly report for fiscal 2024
- Matinas BioPharma Holdings, Inc. 10-Q 2023MTNB 10-Q 2023: quarterly report for fiscal 2023
- Matinas BioPharma Holdings, Inc. 10-Q 2022MTNB 10-Q 2022: quarterly report for fiscal 2022
- Matinas BioPharma Holdings, Inc. 8-K 2026MTNB 8-K 2026: current report for fiscal 2026
- Matinas BioPharma Holdings, Inc. 8-K 2025MTNB 8-K 2025: current report for fiscal 2025
- Matinas BioPharma Holdings, Inc. 8-K 2024MTNB 8-K 2024: current report for fiscal 2024
- Matinas BioPharma Holdings, Inc. 8-K 2023MTNB 8-K 2023: current report for fiscal 2023
- Matinas BioPharma Holdings, Inc. 8-K 2022MTNB 8-K 2022: current report for fiscal 2022
- Matinas BioPharma Holdings, Inc. DEF 14A 2026MTNB DEF 14A 2026: proxy statement for fiscal 2026
- Matinas BioPharma Holdings, Inc. DEF 14A 2025MTNB DEF 14A 2025: proxy statement for fiscal 2025
- Matinas BioPharma Holdings, Inc. DEF 14A 2024MTNB DEF 14A 2024: proxy statement for fiscal 2024
- Matinas BioPharma Holdings, Inc. DEF 14A 2023MTNB DEF 14A 2023: proxy statement for fiscal 2023
- Matinas BioPharma Holdings, Inc. DEF 14A 2022MTNB DEF 14A 2022: proxy statement for fiscal 2022
- Matinas BioPharma Holdings, Inc. Form 4 2026MTNB Form 4 2026: insider trading filing for fiscal 2026
- Matinas BioPharma Holdings, Inc. Form 4 2025MTNB Form 4 2025: insider trading filing for fiscal 2025
- Matinas BioPharma Holdings, Inc. Form 4 2024MTNB Form 4 2024: insider trading filing for fiscal 2024
- Matinas BioPharma Holdings, Inc. Form 4 2023MTNB Form 4 2023: insider trading filing for fiscal 2023
- Matinas BioPharma Holdings, Inc. Form 4 2022MTNB Form 4 2022: insider trading filing for fiscal 2022
- Matinas BioPharma Holdings, Inc. S-1 2026MTNB S-1 2026: registration statement for fiscal 2026
- Matinas BioPharma Holdings, Inc. S-1 2025MTNB S-1 2025: registration statement for fiscal 2025
- Matinas BioPharma Holdings, Inc. S-1 2024MTNB S-1 2024: registration statement for fiscal 2024
- Matinas BioPharma Holdings, Inc. S-1 2023MTNB S-1 2023: registration statement for fiscal 2023
- Matinas BioPharma Holdings, Inc. S-1 2022MTNB S-1 2022: registration statement for fiscal 2022
- Matinas BioPharma Holdings, Inc. 13F 2026MTNB 13F 2026: institutional holdings for fiscal 2026
- Matinas BioPharma Holdings, Inc. 13F 2025MTNB 13F 2025: institutional holdings for fiscal 2025
- Matinas BioPharma Holdings, Inc. 13F 2024MTNB 13F 2024: institutional holdings for fiscal 2024
- Matinas BioPharma Holdings, Inc. 13F 2023MTNB 13F 2023: institutional holdings for fiscal 2023
- Matinas BioPharma Holdings, Inc. 13F 2022MTNB 13F 2022: institutional holdings for fiscal 2022
More companies